Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus live recombinant microbicides

Theoretical Biology & Medical Modelling
Misaki WayengeraWilson Byarugaba

Abstract

Herpes Simplex virus types 1 and 2 are enveloped viruses with a linear dsDNA genome of approximately 120-200 kb. Genital infection with HSV-2 has been denoted as a major risk factor for acquisition and transmission of HIV-1. Developing biomedical strategies for HSV-2 prevention is thus a central strategy in reducing global HIV-1 prevalence. This paper details the protocol for the isolation of restriction endunucleases (REases) with potent activity against the HSV-2 genome and models two biomedical interventions for preventing HSV-2. Using the whole genome of HSV-2, 289 REases and the bioinformatics software Webcutter2; we searched for potential recognition sites by way of genome wide palindromics. REase application in HSV-2 biomedical therapy was modeled concomitantly. Of the 289 enzymes analyzed; 77(26.6%) had potential to cleave the HSV-2 genome in > 100 but < 400 sites; 69(23.9%) in > 400 but < 700 sites; and the 9(3.1%) enzymes: BmyI, Bsp1286I, Bst2UI, BstNI, BstOI, EcoRII, HgaI, MvaI, and SduI cleaved in more than 700 sites. But for the 4: PacI, PmeI, SmiI, SwaI that had no sign of activity on HSV-2 genomic DNA, all 130(45%) other enzymes cleaved < 100 times. In silico palindromics has a PPV of 99.5% for in situ REase acti...Continue Reading

References

Feb 1, 1992·Virology·D M MargolisJ M Ostrove
Sep 1, 1992·The Journal of Infectious Diseases·M P GoldenM A Albrecht
May 25, 1990·Nucleic Acids Research·E WagnerC Kessler
Dec 22, 1989·Biochimica Et Biophysica Acta·V KossykhY Buryanov
Jan 1, 1985·The Journal of Clinical Investigation·A L CunninghamT C Merigan
Nov 16, 1981·FEBS Letters·A JanulaitisA Mironov
Mar 11, 1982·Nucleic Acids Research·L H HuangM Ehrlich
Jun 1, 1995·Genitourinary Medicine·Y Adu-Sarkodie
Jun 1, 1994·American Journal of Public Health·M Potts
Apr 10, 1997·The New England Journal of Medicine·R A RoyceM S Cohen
Jun 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·N E Murray
Jun 29, 2002·Nature Biotechnology·Carina KrügerLennart Hammarstrom
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F X Mbopi-KeouD W G Brown
Jun 26, 2003·Nucleic Acids Research·Elisabeth GasteigerAmos Bairoch
May 13, 2006·Journal of Biomaterials Science. Polymer Edition·Carlos E Astete, Cristina M Sabliov
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Dec 13, 2006·Cancer Immunology, Immunotherapy : CII·John F DijosephNitin K Damle
Feb 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ravi P Subramanian, Robert J Geraghty
Jun 10, 2008·Applied and Environmental Microbiology·Xiaowen LiuQiang Xu
Jan 10, 2013·BMC Microbiology·Hidemi S YamamotoRaina N Fichorova

Methods Mentioned

BETA
PCR
xenografts
light scattering

Related Concepts

Endodeoxyribonuclease MvaI
Microbicides
DNA Restriction Enzymes
Peptide Fragments
Viral Proteins
Type II site-specific deoxyribonuclease
HIV Infections
Viral Genome
Human Herpesvirus 2
Medical Research Activity

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.